CervoMed Inc. (CRVO) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "CRVO"
      ],
      "issuer_cik": "0001053691",
      "owner_cik": "0001197023",
      "accession_number": "0001437749-26-020691",
      "form_type": "4",
      "filing_date": "2026-06-15",
      "period_of_report": "2026-06-11",
      "issuer_name": "CervoMed Inc.",
      "issuer_trading_symbol": "CRVO",
      "owner_name": "BOGER JOSHUA S",
      "is_director": true,
      "is_ten_percent_owner": true,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-06-11",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 955414,
      "transaction_price_per_share": 3.14,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 1795865,
      "transaction_value": 2999999.96,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By Trusts",
      "footnotes": [
        {
          "id": "F1",
          "description": "On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."
        },
        {
          "id": "F2",
          "description": "After giving effect to all transactions described herein, consists of (i) 1,600,117 shares of the Issuer's common stock held by the JSB 2021 Trust and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."
        }
      ]
    },
    {
      "tickers": [
        "CRVO"
      ],
      "issuer_cik": "0001053691",
      "owner_cik": "0001971400",
      "accession_number": "0001437749-25-035655",
      "form_type": "4",
      "filing_date": "2025-11-19",
      "period_of_report": "2025-11-17",
      "issuer_name": "CervoMed Inc.",
      "issuer_trading_symbol": "CRVO",
      "owner_name": "Winton Matthew",
      "is_officer": true,
      "officer_title": "Chief Commercial and Business",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2025-11-17",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 3500,
      "transaction_price_per_share": 8.43,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 13500,
      "transaction_value": 29505,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Shares purchased in open-market transactions."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.